Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer
PHASE1CompletedINTERVENTIONAL
Timeline
Start Date
April 30, 2000
Primary Completion Date
July 31, 2005
Conditions
Colorectal CancerEsophageal CancerKidney CancerLung CancerPancreatic CancerProstate Cancer
Interventions
BIOLOGICAL
panitumumab
Trial Locations (2)
19111
Fox Chase Cancer Center, Philadelphia
90095-1738
Jonsson Comprehensive Cancer Center, UCLA, Los Angeles
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
Jonsson Comprehensive Cancer Center
OTHER
NCT00004879 - Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer | Biotech Hunter | Biotech Hunter